0.87
price down icon0.17%   -0.0015
after-market アフターアワーズ: .94 0.07 +8.05%
loading
前日終値:
$0.8715
開ける:
$0.89
24時間の取引高:
1.67M
Relative Volume:
0.91
時価総額:
$88.68M
収益:
$153.73M
当期純損益:
$-106.79M
株価収益率:
-0.4888
EPS:
-1.78
ネットキャッシュフロー:
$-115.93M
1週間 パフォーマンス:
-17.14%
1か月 パフォーマンス:
+44.42%
6か月 パフォーマンス:
-78.68%
1年 パフォーマンス:
-79.04%
1日の値動き範囲:
Value
$0.8564
$1.00
1週間の範囲:
Value
$0.8564
$1.03
52週間の値動き範囲:
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
名前
Sutro Biopharma Inc
Name
セクター
Healthcare (1155)
Name
電話
650-392-8412
Name
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
310
Name
Twitter
@SutroBio
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
STRO's Discussions on Twitter

STRO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
STRO
Sutro Biopharma Inc
0.87 88.68M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
439.37 128.45B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.63 65.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
560.90 40.09B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.19 35.67B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
233.25 27.44B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-17 ダウングレード H.C. Wainwright Buy → Neutral
2025-03-14 ダウングレード BofA Securities Buy → Underperform
2025-03-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 ダウングレード Wedbush Outperform → Neutral
2024-05-08 開始されました BofA Securities Buy
2023-11-09 開始されました Deutsche Bank Buy
2023-10-06 開始されました Oppenheimer Outperform
2023-03-21 ダウングレード Wells Fargo Overweight → Equal Weight
2022-08-18 再開されました Wells Fargo Overweight
2021-06-18 開始されました H.C. Wainwright Buy
2020-12-03 開始されました Stifel Buy
2020-09-02 開始されました Jefferies Buy
2020-07-16 開始されました Wells Fargo Overweight
2020-01-13 開始されました SunTrust Buy
2019-10-07 開始されました BTIG Research Buy
2019-07-18 開始されました Deutsche Bank Buy
2019-04-29 開始されました H.C. Wainwright Buy
2018-10-22 開始されました JMP Securities Mkt Outperform
2018-10-22 開始されました Piper Jaffray Overweight
2018-10-22 開始されました Wedbush Outperform
すべてを表示

Sutro Biopharma Inc (STRO) 最新ニュース

pulisher
08:01 AM

Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

08:01 AM
pulisher
03:26 AM

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World

03:26 AM
pulisher
May 10, 2025

Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada

May 09, 2025
pulisher
May 08, 2025

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 08, 2025
pulisher
May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq

May 08, 2025
pulisher
May 07, 2025

Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX

May 07, 2025
pulisher
May 06, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World

May 06, 2025
pulisher
May 02, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 02, 2025
pulisher
May 01, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan

May 01, 2025
pulisher
May 01, 2025

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga

May 01, 2025
pulisher
May 01, 2025

Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Taking the lead: Sutro Biopharma Inc (STRO) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Price Target at $6.63 - The AM Reporter

Apr 30, 2025
pulisher
Apr 29, 2025

Sutro Biopharma Inc [STRO] Investment Appeal on the Rise - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

A stock that deserves closer examination: Sutro Biopharma Inc (STRO) - uspostnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

Sutro Biopharma to Highlight its Next-Generation Exatecan and Du - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025 - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Sutro Biopharma Announces Poster Presentations on STRO-004 and XpressCF+® Platform at 2025 AACR Annual Meeting - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Revolutionary Dual-Payload Cancer Drug Shows Promise: Sutro's Next-Gen ADC Technology Impresses at AACR 2025 - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Sutro Biopharma Inc (STRO) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Apr 28, 2025
pulisher
Apr 27, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Analysts - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Russell Investments Group Ltd. Has $183,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

New fund will pressure flailing biotechs, as investor frustration boils over - Endpoints News

Apr 25, 2025
pulisher
Apr 23, 2025

LPL Financial LLC Has $667,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

Sutro Biopharma Inc (STRO) gets rating Downgrade from H.C. Wainwright - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Anchoring Your Portfolio: Is STRO Stock a Safe Harbor? - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Take off with Sutro Biopharma Inc (STRO): Get ready for trading - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Sutro Biopharma Inc (NASDAQ: STRO) – Analysts’ Revisions Point To Positive Sentiment - Stocksregister

Apr 22, 2025
pulisher
Apr 22, 2025

Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace

Apr 22, 2025
pulisher
Apr 18, 2025

Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st

Apr 18, 2025
pulisher
Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada

Apr 16, 2025
pulisher
Apr 15, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Holdings Boosted by American Century Companies Inc. - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Sutro Biopharma announces board member departure By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Sutro Biopharma announces board member departure - Investing.com Australia

Apr 14, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Takes Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 12, 2025
pulisher
Apr 07, 2025

Changing FacesPharma and Biotech HiresMarch 2025 - pharmaphorum

Apr 07, 2025
pulisher
Apr 07, 2025

Prudential Financial Inc. Increases Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Acquires Shares of 97,096 Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Hold” from Analysts - Defense World

Apr 02, 2025

Sutro Biopharma Inc (STRO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.75
price up icon 4.10%
$19.93
price up icon 2.94%
$33.35
price up icon 0.60%
$25.26
price up icon 5.43%
$97.27
price up icon 4.85%
biotechnology ONC
$233.25
price up icon 0.54%
大文字化:     |  ボリューム (24 時間):